AtriCure - Stock Price History | ATRC
Historical daily share price chart and data for AtriCure since 2020 adjusted for splits. The latest closing stock price for AtriCure as of October 23, 2020 is 37.96.
- The all-time high AtriCure stock closing price was 51.19 on June 08, 2020.
- The AtriCure 52-week high stock price is 51.76, which is 36.4% above the current share price.
- The AtriCure 52-week low stock price is 23.16, which is 39% below the current share price.
- The average AtriCure stock price for the last 52 weeks is 38.60.
| AtriCure Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 29.1289 | 30.2500 | 33.3400 | 23.8100 | 32.5100 | 6.24% |
| 2018 | 26.1470 | 18.4700 | 35.5800 | 15.0500 | 30.6000 | 67.76% |
| 2017 | 20.3076 | 19.2000 | 24.8800 | 14.9400 | 18.2400 | -6.80% |
| 2016 | 16.5649 | 21.1600 | 21.4700 | 13.5400 | 19.5700 | -12.79% |
| 2015 | 21.8535 | 19.7800 | 27.9300 | 17.4000 | 22.4400 | 12.42% |
| 2014 | 17.5247 | 18.0300 | 22.1800 | 13.6400 | 19.9600 | 6.85% |
| 2013 | 10.3316 | 7.1400 | 18.9300 | 7.1400 | 18.6800 | 170.72% |
| 2012 | 8.5684 | 11.7400 | 11.9600 | 5.9100 | 6.9000 | -37.84% |
| 2011 | 11.4511 | 10.2500 | 14.5000 | 8.5400 | 11.1000 | 8.08% |
| 2010 | 6.7755 | 5.6500 | 10.2700 | 4.5600 | 10.2700 | 70.03% |
| 2009 | 3.2447 | 2.2000 | 6.0500 | 1.0700 | 6.0400 | 172.07% |
| 2008 | 9.7793 | 13.2400 | 14.0500 | 2.0000 | 2.2200 | -83.07% |
| 2007 | 10.6159 | 9.1500 | 13.5900 | 8.4400 | 13.1100 | 46.64% |
| 2006 | 8.1361 | 10.7900 | 11.8000 | 5.4400 | 8.9400 | -16.06% |
| 2005 | 13.1674 | 14.0800 | 14.9500 | 10.6500 | 10.6500 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.720B | $0.231B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $193.838B | 34.76 |
| Medtronic (MDT) | Ireland | $150.337B | 28.31 |
| Stryker (SYK) | United States | $84.201B | 32.65 |
| Boston Scientific (BSX) | United States | $52.735B | 30.46 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.915B | 0.00 |
| Baxter (BAX) | United States | $41.233B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $29.618B | 24.58 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.595B | 0.00 |
| Terumo (TRUMY) | Japan | $28.421B | 36.33 |
| ResMed (RMD) | United States | $26.492B | 38.41 |
| Sunny Optical Technology (SNPTF) | China | $17.297B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $17.185B | 77.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.848B | 0.00 |
| Insulet (PODD) | United States | $16.101B | 681.25 |
| DiaSorin S.p.A (DSRLF) | Italy | $12.588B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.080B | 0.00 |
| Quidel (QDEL) | United States | $10.309B | 54.61 |
| GN STORE NORD (GNNDY) | Denmark | $9.996B | 50.95 |
| William Demant Holdings (WILYY) | Denmark | $8.193B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.547B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.207B | 10.65 |
| Hill-Rom Holdings (HRC) | United States | $6.066B | 15.05 |
| Haemonetics (HAE) | United States | $5.406B | 36.02 |
| Envista Holdings (NVST) | United States | $4.393B | 29.96 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.124B | 0.00 |
| ICU Medical (ICUI) | United States | $4.064B | 31.01 |
| Abcam (ABCZY) | $3.897B | 0.00 | |
| Neogen (NEOG) | United States | $3.787B | 62.09 |
| TG Therapeutics (TGTX) | United States | $3.474B | 0.00 |
| National Vision Holdings (EYE) | United States | $3.425B | 532.38 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.013B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.686B | 0.00 |
| NuVasive (NUVA) | United States | $2.649B | 36.91 |
| DFB Healthcare Acquisitions (AHCO) | United States | $2.230B | 0.00 |
| Owens & Minor (OMI) | United States | $1.548B | 34.67 |
| Cardiovascular Systems (CSII) | United States | $1.541B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.393B | 0.00 |
| Aphria (APHA) | Canada | $1.351B | 0.00 |
| InMode (INMD) | Israel | $1.336B | 33.71 |
| MacroGenics (MGNX) | United States | $1.227B | 0.00 |
| Quanterix (QTRX) | United States | $1.162B | 0.00 |
| OraSure Technologies (OSUR) | United States | $1.057B | 0.00 |
| Cerus (CERS) | United States | $1.049B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.915B | 476.33 |
| Lantheus Holdings (LNTH) | United States | $0.869B | 12.05 |
| PetIQ (PETQ) | United States | $0.869B | 24.92 |
| Vapotherm (VAPO) | United States | $0.801B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.785B | 18.14 |
| Phibro Animal Health (PAHC) | United States | $0.737B | 16.86 |
| LeMaitre Vascular (LMAT) | United States | $0.657B | 40.11 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.646B | 91.33 |
| Omeros (OMER) | United States | $0.602B | 0.00 |
| Varex Imaging (VREX) | United States | $0.560B | 24.29 |
| Aurora Cannabis (ACB) | Canada | $0.560B | 0.00 |
| Surmodics (SRDX) | United States | $0.556B | 60.99 |
| Zynex (ZYXI) | United States | $0.494B | 43.15 |
| Viemed Healthcare (VMD) | United States | $0.377B | 13.40 |
| HEXO (HEXO) | $0.364B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.356B | 0.00 |
| Surface Oncology (SURF) | United States | $0.352B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.306B | 26.25 |
| InfuSystems Holdings (INFU) | United States | $0.268B | 51.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.257B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.243B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.219B | 0.00 |
| Bovie Medical (APYX) | United States | $0.212B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.191B | 0.00 |
| Exagen (XGN) | United States | $0.182B | 0.00 |
| Chimerix (CMRX) | United States | $0.170B | 0.00 |
| Female Health (VERU) | United States | $0.170B | 0.00 |
| Fonar (FONR) | United States | $0.138B | 18.26 |
| Liberty Health Sciences (LHSIF) | United States | $0.127B | 0.00 |
| Evolus (EOLS) | United States | $0.116B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.090B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.070B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.069B | 0.00 |
| United-Guardian (UG) | United States | $0.068B | 15.19 |
| Brainsway (BWAY) | Israel | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.063B | 11.86 |
| Nephros (NEPH) | United States | $0.060B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.060B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.025B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.024B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.021B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.019B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.017B | 0.00 |
| Myomo (MYO) | United States | $0.017B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
